C

Perspective Therapeutics
D

CATX

4.49200
USD
-0.27
(-5.63%)
مغلق
حجم التداول
95,071
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
333,589,351
المقالات

العنوان: Perspective Therapeutics

القطاع: Healthcare
الصناعة: Medical Devices
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotopeLead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.